产品中心
  Wechat

Wechat

  Contact Us

Address:

5th floor, Building 9, No.8 Shengmingyuan Road, Life Science Park, Zhongguancun, Changping District, Beijing, China

Email:

postmaster@sinotau.com

Tel:

+86-10-8492479489934358

Fax:

+86-10-84920734

Overview


Sinotau's R&D center in China is located in Zhongguancun Life Science Park in Beijing. More than 30 researchers work in this facility full-time. Our technical staff is highly qualified, with doctorate and master's degrees among the senior team. The R&D lab occupies a space of 3,000 square meters with an investment of more than 50 million RMB. In this center we conduct, among others R&D activities, drug analysis, pharmaceutical engineering and bioengineering. 


Our R&D team has extensive development knowledge and has managed over thirty research projects. Furthermore, Sinotau's R&D has handled dozens of ANDA filings of foreign formulations for diverse therapeutic areas, including antiretroviral, central nervous system (CNS), cardiovascular system (CVS), diabetes and oncology. In these R&D projects Sinotau has invested nearly 200 million RMB. In 2013, Sinotau set foot in the field of radiopharmaceuticals  organizing a R&D department for nuclear medicine focused on the development of radioactive diagnostics and therapies mainly for oncology, Parkinson's disease, Alzheimer's disease and cardiology.


Sinotau has two antibody R&D labs. One located in the Beijing facilities and the other in the city of Birmingham in the U.S. state of Alabama. Both facilities are fully equipped with cutting edge equipment. In these two labs Sinotau conducts early development of antibody biological drugs. Both labs work together in different projects combining global resources and taking full advantage of in-house high-efficiency/low-cost research tools. So far, these labs are working in several novel quality products in the early stages.